Anas Samman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anas Samman has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Malik
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
1 shared publication - Aemal Akhtar
Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
1 shared publication Alanna Rigobon
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
1 shared publication- Alexander James Roy Bishop
Greehey Children’s Cancer Research Institute, University of Texas Health at San Antonio, San Antonio, USA
1 shared publication Aman Sidhu
Ajmera Transplant Program, University Health Network, Toronto, Ontario, Canada
1 shared publication- Amna Zulfiqar
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
1 shared publication
Latest Publications
- 29 March 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (7) , 937-951
Predictors of 1-year mortality after adult lung transplantation: Systematic review and meta-analyses
- 29 March 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (7) , 937-951
Predictors of 1-year mortality after adult lung transplantation: Systematic review and meta-analyses
- Top Cited Papers
- 15 July 2020
- Published by Springer Nature in Nature
- Vol. 585 (7824) , 298-302
Nucleolar RNA polymerase II drives ribosome biogenesis
Proteins are manufactured by ribosomes—macromolecular complexes of protein and RNA molecules that are assembled within major nuclear compartments called nucleoli1,2. Existing models suggest that RNA polymerases I and III (Pol I and Pol III) are the only enzymes that directly mediate the expression of the ribosomal RNA (rRNA) components of ribosomes. Here we show, however, that RNA polymerase II (Pol II) inside human nucleoli operates near genes encoding rRNAs to drive their expression. Pol II, assisted by the neurodegeneration-associated enzyme senataxin, generates a shield comprising triplex nucleic acid structures known as R-loops at intergenic spacers flanking nucleolar rRNA genes. The shield prevents Pol I from producing sense intergenic noncoding RNAs (sincRNAs) that can disrupt nucleolar organization and rRNA expression. These disruptive sincRNAs can be unleashed by Pol II inhibition, senataxin loss, Ewing sarcoma or locus-associated R-loop repression through an experimental system involving the proteins RNaseH1, eGFP and dCas9 (which we refer to as ‘red laser’). We reveal a nucleolar Pol-II-dependent mechanism that drives ribosome biogenesis, identify disease-associated disruption of nucleoli by noncoding RNAs, and establish locus-targeted R-loop modulation. Our findings revise theories of labour division between the major RNA polymerases, and identify nucleolar Pol II as a major factor in protein synthesis and nuclear organization, with potential implications for health and disease.
- 15 July 2020
- Published by Springer Nature in Nature
- Vol. 585 (7824) , 298-302
Top Cited PapersNucleolar RNA polymerase II drives ribosome biogenesis
Proteins are manufactured by ribosomes—macromolecular complexes of protein and RNA molecules that are assembled within major nuclear compartments called nucleoli1,2. Existing models suggest that RNA polymerases I and III (Pol I and Pol III) are the only enzymes that directly mediate the expression of the ribosomal RNA (rRNA) components of ribosomes. Here we show, however, that RNA polymerase II (Pol II) inside human nucleoli operates near genes encoding rRNAs to drive their expression. Pol II, assisted by the neurodegeneration-associated enzyme senataxin, generates a shield comprising triplex nucleic acid structures known as R-loops at intergenic spacers flanking nucleolar rRNA genes. The shield prevents Pol I from producing sense intergenic noncoding RNAs (sincRNAs) that can disrupt nucleolar organization and rRNA expression. These disruptive sincRNAs can be unleashed by Pol II inhibition, senataxin loss, Ewing sarcoma or locus-associated R-loop repression through an experimental system involving the proteins RNaseH1, eGFP and dCas9 (which we refer to as ‘red laser’). We reveal a nucleolar Pol-II-dependent mechanism that drives ribosome biogenesis, identify disease-associated disruption of nucleoli by noncoding RNAs, and establish locus-targeted R-loop modulation. Our findings revise theories of labour division between the major RNA polymerases, and identify nucleolar Pol II as a major factor in protein synthesis and nuclear organization, with potential implications for health and disease.